Davenport & CO LLC Intellia Therapeutics, Inc. Transaction History

Davenport & CO LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 14, 2021	SELL	$132.37 - $176.78 $1.03 Million - $1.38 Million	-7,800 Closed	0 $0
Q2 2021 Jul 28, 2021	SELL	$60.88 - $161.91 $316,576 - $841,932	-5,200 Reduced 40.0%	7,800 $1.26 Million
Q1 2021 Apr 28, 2021	SELL	$46.59 - $83.68 $232,950 - $418,400	-5,000 Reduced 27.78%	13,000 $1.04 Million
Q4 2020 Jan 13, 2021	SELL	$18.83 - $63.53 $22,595 - $76,236	-1,200 Reduced 6.25%	18,000 $979,000
Q3 2020 Oct 15, 2020	BUY	$17.47 - $24.93 $335,424 - $478,656	19,200 New	19,200 $382,000

314

91.5M

442K

880K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $926M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Davenport & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Davenport & CO LLC with notifications on news.